Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 20.48
-0.48 (-2.29%)
Apr 17, 2026, 3:59 PM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 4.71 billion as of April 16, 2026. Its market cap has increased by 136.03% in one year.
Market Cap
4.71B
Enterprise Value
4.18B
Revenue
897.99M
Ranking
n/a
PE Ratio
13.40
Stock Price
20.48
Market Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 4.71B, a decrease of -6.17%. That is a compound annual growth rate of -3.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 4.71B | 11.12% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 6.57B |
| Jacobio Pharmaceuticals Group | 6.44B |
| Shandong Boan Biotechnology | 4.53B |
| Beijing Luzhu Biotechnology | 4.36B |
| TYK Medicines | 4.24B |
| Antengene Corporation | 4.18B |
| Viva Biotech Holdings | 4.05B |
| Clover Biopharmaceuticals | 3.79B |